JMP Securities Downgrades Optimer Pharmaceuticals (OPTR) to Market Perform

March 1, 2013 8:17 AM EST
Get Alerts OPTR Hot Sheet
Price: $12.78 --0%

Rating Summary:
    4 Buy, 9 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade OPTR Now!
Join SI Premium – FREE
JMP Securities downgraded Optimer Pharmaceuticals (NASDAQ: OPTR) from Market Outperform to Market Perform.

For an analyst ratings summary and ratings history on Optimer Pharmaceuticals click here. For more ratings news on Optimer Pharmaceuticals click here.

Shares of Optimer Pharmaceuticals closed at $12.12 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

JMP Securities

Add Your Comment